Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|
BT-20 | 0 | uM | 7 | 5000.00 | 1243.75 | 1.00 | 7457.00 | 0.0001 | -0.9366 | |
BT-20 | 0 | uM | 7 | 5000.00 | 1243.75 | 7490.00 | 7457.00 | 1.0044 | 1.0034 | |
BT-20 | 0 | uM | 7 | 5000.00 | 1243.75 | 7328.00 | 7457.00 | 0.9827 | 0.9865 | |
BT-20 | 17-AAG | 3.1623 | uM | 7 | 5000.00 | 1243.75 | 2463.00 | 7457.00 | 0.3303 | 0.3027 |
BT-20 | Lapatinib | 0.0033113 | uM | 7 | 5000.00 | 1243.75 | 7303.00 | 7457.00 | 0.9794 | 0.9839 |
BT-20 | Lapatinib | 0.031623 | uM | 7 | 5000.00 | 1243.75 | 7503.00 | 7457.00 | 1.0062 | 1.0048 |
BT-20 | 17-AAG | 0.0033113 | uM | 7 | 5000.00 | 1243.75 | 7691.00 | 7457.00 | 1.0314 | 1.0241 |
BT-20 | Linsitinib | 1 | uM | 7 | 5000.00 | 1243.75 | 7425.00 | 7457.00 | 0.9957 | 0.9967 |
BT-20 | Lapatinib | 0.0016596 | uM | 7 | 5000.00 | 1243.75 | 7500.00 | 7457.00 | 1.0058 | 1.0045 |
BT-20 | 0 | uM | 7 | 5000.00 | 1243.75 | 7704.00 | 7457.00 | 1.0331 | 1.0254 | |
BT-20 | Linsitinib | 0.0033113 | uM | 7 | 5000.00 | 1243.75 | 7833.00 | 7457.00 | 1.0504 | 1.0384 |
BT-20 | Linsitinib | 0.1 | uM | 7 | 5000.00 | 1243.75 | 7729.00 | 7457.00 | 1.0365 | 1.0279 |
BT-20 | Lapatinib | 0.31623 | uM | 7 | 5000.00 | 1243.75 | 7678.00 | 7457.00 | 1.0296 | 1.0227 |
BT-20 | Linsitinib | 0.031623 | uM | 7 | 5000.00 | 1243.75 | 7610.00 | 7457.00 | 1.0205 | 1.0158 |
BT-20 | 17-AAG | 10 | uM | 7 | 5000.00 | 1243.75 | 2489.00 | 7457.00 | 0.3338 | 0.3080 |
BT-20 | Lapatinib | 0.1 | uM | 7 | 5000.00 | 1243.75 | 7400.00 | 7457.00 | 0.9924 | 0.9941 |
BT-20 | 17-AAG | 0.31623 | uM | 7 | 5000.00 | 1243.75 | 2377.00 | 7457.00 | 0.3188 | 0.2849 |
BT-20 | Linsitinib | 10 | uM | 7 | 5000.00 | 1243.75 | 6261.00 | 7457.00 | 0.8396 | 0.8692 |
BT-20 | Linsitinib | 0.31623 | uM | 7 | 5000.00 | 1243.75 | 7874.00 | 7457.00 | 1.0559 | 1.0426 |
BT-20 | Erlotinib | 0.31623 | uM | 7 | 5000.00 | 1243.75 | 6735.00 | 7457.00 | 0.9032 | 0.9227 |
BT-20 | Erlotinib | 3.1623 | uM | 7 | 5000.00 | 1243.75 | 6103.00 | 7457.00 | 0.8184 | 0.8508 |
BT-20 | Erlotinib | 1 | uM | 7 | 5000.00 | 1243.75 | 6381.00 | 7457.00 | 0.8557 | 0.8830 |
BT-20 | 0 | uM | 7 | 5000.00 | 1243.75 | 7506.00 | 7457.00 | 1.0066 | 1.0051 | |
BT-20 | 0 | uM | 7 | 5000.00 | 1243.75 | 0.00 | 7457.00 | 0.0000 | -1.0000 | |
BT-20 | 0 | uM | 7 | 5000.00 | 1243.75 | 2.00 | 7457.00 | 0.0003 | -0.9171 |